Spotlight
Video

ISGIO - Future Directions of Determining Recurrent Risk in Post Surgical Stage 2 and 3 Colon Cancer - Howard Hochster, MD

Loading........
Description: ISGIO - Future Directions of Determining Recurrent Risk in Post Surgical Stage 2 and 3 Colon Cancer - Howard Hochster, MDm- Professor of Medicine Yale Cancer Center. Internationals Society of Gastrointestinal Oncology
Shared By : genomichealth
Posted on : 09/15/12
Added : 5 years ago



More From genomichealth

Nothing found.